- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| CIVITAS SOLUTIONS Aktie jetzt für 0€ handeln |
0 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| DEXCOM | 72,00 | -0,24 % | FDA announces recall of certain Dexcom glucose monitoring devices | ||
| PLUS THERAPEUTICS | 0,384 | 0,00 % | PLUS THERAPEUTICS, INC. - 8-K, Current Report | ||
| CARDINAL HEALTH | 136,55 | -0,51 % | Cardinal Health Launches One Voice Initiative To Empower Pharmacy Advocacy | WASHINGTON (dpa-AFX) - Cardinal Health (CAH) has introduced the Cardinal Health One Voice Initiative, a new program designed to financially support state pharmacy associations in bolstering... ► Artikel lesen | |
| DAVITA | 119,30 | -3,24 % | DAVITA INC. - 8-K, Current Report | ||
| EVOFEM BIOSCIENCES | - | - | Windtree Therapeutics: Windtree Advances Lower Cost Manufacturing of PHEXXI, Evofem's Hormone-Free, On-Demand Prescription Contraceptive Gel | Windtree rapidly advancing lower cost PHEXXI manufacturing under March 2025 sourcing agreement Contract inked with outside U.S manufacturer to cut PHEXXI manufacturing costs by over 50% by end of... ► Artikel lesen | |
| DENTSPLY SIRONA | 13,500 | +0,07 % | Dentsply Sirona CEO Simon Campion To Quit, Daniel Scavilla To Succeed; Announces Q2 Prelim. Results | WASHINGTON (dpa-AFX) - Dentsply Sirona Inc. (XRAY), Monday announced that President and Chief Executive Officer Simon Campion has decided to leave the company on July 31, 2025.The company also... ► Artikel lesen | |
| CENTENE | 23,580 | -1,93 % | Centene-Aktie verliert 4,01 Prozent (25,1966 €) | Am US-amerikanischen Aktienmarkt liegt der Anteilsschein von Centene gegenwärtig im Minus. Der jüngste Kurs betrug 29,19 US-Dollar. An der Börse liegt der Anteilsschein von Centene derzeit im Minus.... ► Artikel lesen | |
| CYTOSORBENTS | 0,921 | +4,42 % | Cytosorbents Corp: CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR | PRINCETON, N.J., July 2, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies for life-threatening conditions... ► Artikel lesen | |
| COOPER COMPANIES | 62,00 | -0,80 % | 6 Analysts Have This To Say About Cooper Companies | ||
| EKSO BIONICS | 3,960 | 0,00 % | Ekso Bionics Holdings, Inc.: Virtual eksoUniversity to Support Continuing Education of PTs and PTAs Across the Country | ||
| FULGENT GENETICS | 15,300 | 0,00 % | Fulgent Genetics gets EU approval for germline sequencing system | ||
| IMUNON | 0,505 | +7,45 % | Imunon, Inc.: IMUNON Granted Continued Listing Extension by Nasdaq to Complete Compliance Plan | Management provides Nasdaq Hearing Panel with a comprehensive executable plan for long term compliance LAWRENCEVILLE, N.J., July 15, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage... ► Artikel lesen | |
| DELCATH SYSTEMS | 9,650 | -0,52 % | Delcath Systems Targets Positive Adj. EBITDA In Each Quarter Of 2025 | WASHINGTON (dpa-AFX) - Delcath Systems (DCTH) said its financial outlook for fiscal 2025 is: total CHEMOSAT and HEPZATO KIT revenue of $94 to $98 million, an increase of more than 150% over... ► Artikel lesen | |
| CAREDX | 11,075 | +8,00 % | CareDx rebounds as draft LCD suggests no change in coverage | ||
| COMMUNITY HEALTH SYSTEMS | 3,040 | -1,30 % | COMMUNITY HEALTH SYSTEMS INC - 8-K, Current Report |
Das Unternehmen CIVITAS SOLUTIONS INC kann der Branche Gesundheitswesen zugeordnet werden.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CIVITAS SOLUTIONS INC finden Sie auf Wallstreet Online.